Catalog No.: PC-Ab1074Not For Human Use, Lab Use Only.
MDX-1342 is a fully human monoclonal antibody with enhanced antibody-dependent cellular cytotoxicity (ADCC) effector function, targeting CD19-membrane receptor which is highly expressed on malignant chronic lymphocytic leukemia (CLL) cells. MDX-1342 blocks activation of B cell stimulation, decreasing the number of cancerous B cell clones..
MDX-1342 is a fully human monoclonal antibody with enhanced antibody-dependent cellular cytotoxicity (ADCC) effector function, targeting CD19-membrane receptor which is highly expressed on malignant chronic lymphocytic leukemia (CLL) cells. MDX-1342 blocks activation of B cell stimulation, decreasing the number of cancerous B cell clones.
Physicochemical Properties
M.Wt
Formula
Human IgG1-Kappa
Appearance
Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility
PBS, pH 7.0
Contains no stabilizers or preservatives
